Amalgamated Financial’s AbbVie ABBV Stock Holding History

Amalgamated Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$76.4M	Buy	+471,210	New	+$68.4M	0.61%	20

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Amalgamated Financial's ABBV Position: Q1 2022 in Review

Amalgamated Financial opened a new position in AbbVie (ABBV) in Q1 2022: 471,210 shares worth $76.4M. The stake represents 0.61% of the portfolio and ranks #20 among its holdings.

3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Amalgamated Financial held 471,210 shares of AbbVie worth $76.4M as of Q1 2022.
AbbVie was a new Amalgamated Financial position in Q1 2022.
AbbVie made up 0.61% of Amalgamated Financial's portfolio in Q1 2022, its #20 holding.
3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.